Where each model wins on economics
Portal-gated exclusive pricing can win when a clinic's volume is high enough to extract aggressive negotiated network rates, and when the buyer accepts the Apply & Verify gate before confirming per-vial cost. Scripts advertises 'elite pricing' and cites clinic testimonials of cutting medication costs by nearly 50% — upside from concentrated buying power across hundreds of clinic partners. The risk is that the rate is unverifiable up front and may pair with shipping, processing, or platform fees that change true landed cost. Pass-through pricing wins when a clinic needs to quote cash-pay patients on landed cost before the consult, wants drug cost and facilitation fee separated on the screen, and values seeing the number on every SKU before ordering.
Most cash-pay clinics care most about one thing: knowing per-vial cost before they set patient pricing. That single requirement tends to favor pass-through, because portal rates that arrive after Apply & Verify cannot inform pricing you need to set during evaluation. But a telehealth brand already comfortable with sales-led vetting, concierge fulfillment, and 503B bulk access may rationally prefer Scripts's network model — the right answer depends on the clinic, not the marketing headline.